Résultats de la recherche - 1 result
Factors for severe outcomes following SARS-CoV-2 infection in people with cystic fibrosis in Europe.
therapy were lung transplantation, cystic fibrosis-related diabetes (CFRD), moderate or severe lung disease and azithromycin use (often considered a surrogate marker for infection and poorer lung function). ...